Tag Archives: Prescription Dermatology Therapeutics Market

Prescription Dermatology Therapeutics Market : Precise Analysis on Business Overview, Product Scope And Ongoing Market Development 2026

Prescription Dermatology Therapeutics Market – Snapshot

The ****** prescription dermatology therapeutics market is growing at a rapid pace due to high prevalence and increase in incidence rate of chronic and infectious dermatological disorders, and new product development and commercialization across the globe. In terms of revenue, the ****** market was valued at US$ 27,580.0 Mn in 2017 and is projected to reach US$ 61,296.1 Mn by 2026, expanding at a CAGR of 9.5% from 2018 to 2026. The ****** prescription dermatology therapeutics market is also driven by rise in adoption of biologics for the treatment of moderate to severe dermatological disorders, especially psoriasis, and large patient population with unmet medical needs across the globe.

Prescription Dermatology Therapeutics Market Outlook, Competitive Landscape and Forecasts to 2025

Skin is the largest organ of the body, and the first point of contact for microbes and toxins, any functional issue with it makes the person pay high prices for it. It contains a rich habitat of microbes which results in various dysfunctions, and this is the point where dermatology steps in. The importance of skin has increased in the recent years. High range of population is willing to treat various dermatological diseases due to awareness. Expansion of the number of indications treated by topical drugs is likely to drive the growth of the dermatology drugs market. Historically acne and rosacea have been the primary indications treated, however ongoing research and development efforts focused on new signs such as hair growth, discoloration, and onychomycosis promise to increase the range of uses for prescription dermatology therapeutics and as a result, expand the addressable market of the prescription dermatology therapeutics.